FDA offers suite of new guidance on AI, accelerated approvals, clinical trials and more

With two weeks un­til Pres­i­dent-elect Don­ald Trump’s ad­min­is­tra­tion takes over, the FDA on Mon­day re­leased dozens of new draft and fi­nal guid­ance doc­u­ments cov­er­ing every­thing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.